Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…
0,767€
5,54%
Echtzeit-Aktienkurs Pharming Group N.V.
Bid:
Ask:
Nachrichten zur Pharming Group N.V. Aktie
Pharming Group to participate in March investor conference
Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in…
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...
^
Original-Research: Pharming Group NV - from First Berlin Equity Research
GmbH
29.10.2024 / 14:51 CET/CEST
Dissemination of a Research,…
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...
^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH29.10.2024 / 14:51 CET/CESTDissemination of a Research, transmitted by EQS News…
Pharming Group to report third quarter 2024 financial results on October 24
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Pharming Group to participate in September investor conferences
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate…
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...
^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH26.08.2024 / 15:55 CET/CESTDissemination of a Research, transmitted by EQS News…
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...
^
Original-Research: Pharming Group NV - from First Berlin Equity Research
GmbH
26.08.2024 / 15:55 CET/CEST
Dissemination of a Research,…
Pharming Group reports second quarter and first half 2024 financial results and provides business update
Leiden, the Netherlands, August 1, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary…
Pharming Group to report second quarter and first half 2024 financial results on August 1
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Pharming Group N.V. 2024 Q1 - Results - Earnings Call Presentation
…
Pharming Group N.V. (PHAR) Q1 2024 Earnings Call Transcript
…
Pharming Group to report first quarter 2024 financial results on May 8
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest…
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…
Pharming Group announces the placement of €100 million convertible bonds due 2029
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…
Pharming Group announces the 2024 Annual General Meeting of Shareholders
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…
Pharming Group N.V. (PHAR) Q4 2023 Earnings Call Transcript
…
Pharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation
…
Pharming Group reports fourth quarter and full year 2023 financial results
Leiden, The Netherlands, March 14, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):...
^
Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research…
Original-Research: Pharming (von First Berlin Equity Research GmbH): Buy
^
Original-Research: Pharming - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research GmbH zu…